1. Home
  2. TELA vs PYXS Comparison

TELA vs PYXS Comparison

Compare TELA & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • PYXS
  • Stock Information
  • Founded
  • TELA 2012
  • PYXS 2018
  • Country
  • TELA United States
  • PYXS United States
  • Employees
  • TELA N/A
  • PYXS N/A
  • Industry
  • TELA Medical/Dental Instruments
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TELA Health Care
  • PYXS Health Care
  • Exchange
  • TELA Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • TELA 80.7M
  • PYXS 75.0M
  • IPO Year
  • TELA 2019
  • PYXS 2021
  • Fundamental
  • Price
  • TELA $2.13
  • PYXS $1.14
  • Analyst Decision
  • TELA Strong Buy
  • PYXS Strong Buy
  • Analyst Count
  • TELA 4
  • PYXS 5
  • Target Price
  • TELA $6.00
  • PYXS $9.00
  • AVG Volume (30 Days)
  • TELA 58.1K
  • PYXS 706.0K
  • Earning Date
  • TELA 08-11-2025
  • PYXS 08-13-2025
  • Dividend Yield
  • TELA N/A
  • PYXS N/A
  • EPS Growth
  • TELA N/A
  • PYXS N/A
  • EPS
  • TELA N/A
  • PYXS N/A
  • Revenue
  • TELA $71,217,000.00
  • PYXS N/A
  • Revenue This Year
  • TELA $26.67
  • PYXS N/A
  • Revenue Next Year
  • TELA $22.63
  • PYXS N/A
  • P/E Ratio
  • TELA N/A
  • PYXS N/A
  • Revenue Growth
  • TELA 12.78
  • PYXS N/A
  • 52 Week Low
  • TELA $0.86
  • PYXS $0.83
  • 52 Week High
  • TELA $4.78
  • PYXS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • TELA 61.31
  • PYXS 51.44
  • Support Level
  • TELA $1.95
  • PYXS $1.13
  • Resistance Level
  • TELA $2.16
  • PYXS $1.23
  • Average True Range (ATR)
  • TELA 0.16
  • PYXS 0.07
  • MACD
  • TELA -0.01
  • PYXS 0.00
  • Stochastic Oscillator
  • TELA 63.17
  • PYXS 76.15

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: